Robert Azelby

Insider Reports History

Entity
Individual
Location
307 Westlake Ave. North, Ste 300, Seattle, WA
Signature
/s/ James E. Barnett, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robert Azelby:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CARDINAL HEALTH INC Director Common Shares 3.02K $330K $109.39 Nov 6, 2024 Direct
ADC Therapeutics SA Director Common Shares 53K $153K $2.89 Jun 17, 2024 Direct
Eliem Therapeutics, Inc. President & CEO, Director Stock Option (Right to Buy) 500K Oct 31, 2022 Direct
Clovis Oncology, Inc. Director Stock Option (right to buy) 42.2K Jun 10, 2021 Direct
CHINOOK THERAPEUTICS, INC. Director Restricted Stock Units 0 Aug 11, 2023 Direct
CHINOOK THERAPEUTICS, INC. Director Stock Option (Right to Buy) 0 $26.12 Aug 11, 2023 Direct

Insider Reports Filed by Robert Azelby

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CAH CARDINAL HEALTH INC Nov 6, 2024 1 $0 4 Nov 7, 2024 Director
ADCT ADC Therapeutics SA Jun 17, 2024 1 -$20.2K 4 Jun 18, 2024 Director
ADCT ADC Therapeutics SA Jun 13, 2024 1 $0 4 Jun 14, 2024 Director
CAH CARDINAL HEALTH INC Mar 15, 2024 1 $0 4 Mar 18, 2024 Director
CAH CARDINAL HEALTH INC Mar 1, 2024 0 $0 3 Mar 1, 2024 Director
ADCT ADC Therapeutics SA Jan 2, 2024 0 $0 3 Jan 2, 2024 Director
KDNY CHINOOK THERAPEUTICS, INC. Aug 11, 2023 2 -$519K 4 Aug 11, 2023 Director
KDNY CHINOOK THERAPEUTICS, INC. Apr 10, 2023 2 $0 4 Apr 12, 2023 Director
KDNY CHINOOK THERAPEUTICS, INC. Apr 10, 2023 0 $0 3 Apr 12, 2023 Director
ELYM Eliem Therapeutics, Inc. Oct 31, 2022 1 $0 4 Nov 2, 2022 President & CEO, Director
ELYM Eliem Therapeutics, Inc. Jan 27, 2022 1 $0 4 Jan 31, 2022 President & CEO, Director
ELYM Eliem Therapeutics, Inc. Aug 9, 2021 0 $0 3 Aug 9, 2021 Chief Executive Officer, Director
CLVS Clovis Oncology, Inc. Jun 10, 2021 1 $0 4 Jun 11, 2021 Director